BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29183815)

  • 1. Bioscavenger is effective as a delayed therapeutic intervention following percutaneous VX poisoning in the guinea-pig.
    Mann TM; Price ME; Whitmore CL; Perrott RL; Laws TR; McColm RR; Emery ER; Tattersall JEH; Green AC; Rice H
    Toxicol Lett; 2018 Sep; 293():198-206. PubMed ID: 29183815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of HI-6 DMS in a sustained infusion against percutaneous VX poisoning in the guinea-pig.
    Whitmore C; Cook AR; Mann T; Price ME; Emery E; Roughley N; Flint D; Stubbs S; Armstrong SJ; Rice H; Tattersall JEH
    Toxicol Lett; 2018 Sep; 293():207-215. PubMed ID: 29129798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential role of bioscavenger in the medical management of nerve-agent poisoned casualties.
    Rice H; Mann TM; Armstrong SJ; Price ME; Green AC; Tattersall JEH
    Chem Biol Interact; 2016 Nov; 259(Pt B):175-181. PubMed ID: 27144491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human plasma-derived BuChE as a stoichiometric bioscavenger for treatment of nerve agent poisoning.
    Mumford H; Docx CJ; Price ME; Green AC; Tattersall JE; Armstrong SJ
    Chem Biol Interact; 2013 Mar; 203(1):160-6. PubMed ID: 22981459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-exposure therapy with human butyrylcholinesterase following percutaneous VX challenge in guinea pigs.
    Mumford H; E Price M; Lenz DE; Cerasoli DM
    Clin Toxicol (Phila); 2011 Apr; 49(4):287-97. PubMed ID: 21563904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and physiological effects of human butyrylcholinesterase as a post-exposure therapy against percutaneous poisoning by VX in the guinea-pig.
    Mumford H; Price ME; Cerasoli DM; Teschner W; Ehrlich H; Schwarz HP; Lenz DE
    Chem Biol Interact; 2010 Sep; 187(1-3):304-8. PubMed ID: 20176007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive evaluation of the efficacy of leading oxime therapies in guinea pigs exposed to organophosphorus chemical warfare agents or pesticides.
    Wilhelm CM; Snider TH; Babin MC; Jett DA; Platoff GE; Yeung DT
    Toxicol Appl Pharmacol; 2014 Dec; 281(3):254-65. PubMed ID: 25448441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of HI 6 treatment after percutaneous VR exposure by use of a kinetic-based dynamic computer model.
    Aurbek N; Thiermann H; Szinicz L; Worek F
    Toxicology; 2007 Apr; 233(1-3):173-9. PubMed ID: 16904808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing of decontamination and treatment in case of percutaneous VX poisoning: a mini review.
    Joosen MJ; van der Schans MJ; Kuijpers WC; van Helden HP; Noort D
    Chem Biol Interact; 2013 Mar; 203(1):149-53. PubMed ID: 23085122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of kinetic-based computer modelling to evaluate the efficacy of HI 6 in percutaneous VX poisoning.
    Aurbek N; Thiermann H; Szinicz L; Eyer P; Worek F
    Toxicology; 2006 Jul; 224(1-2):74-80. PubMed ID: 16740352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superior efficacy of HI-6 dimethanesulfonate over pralidoxime methylsulfate against Russian VX poisoning in cynomolgus monkeys (Macaca fascicularis).
    Reymond C; Jaffré N; Taudon N; Menneteau M; Chaussard H; Denis J; Castellarin C; Dhote F; Dorandeu F
    Toxicology; 2018 Dec; 410():96-105. PubMed ID: 30218682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-exposure therapy with recombinant human BuChE following percutaneous VX challenge in guinea-pigs.
    Mumford H; Troyer JK
    Toxicol Lett; 2011 Sep; 206(1):29-34. PubMed ID: 21620937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single treatment of VX poisoned guinea pigs with the phosphotriesterase mutant C23AL: Intraosseous versus intravenous injection.
    Wille T; Neumaier K; Koller M; Ehinger C; Aggarwal N; Ashani Y; Goldsmith M; Sussman JL; Tawfik DS; Thiermann H; Worek F
    Toxicol Lett; 2016 Sep; 258():198-206. PubMed ID: 27397758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel approach to assessing percutaneous VX poisoning in the conscious guinea-pig.
    Mumford H; Price ME; Wetherell JR
    J Appl Toxicol; 2008 Jul; 28(5):694-702. PubMed ID: 18059069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of the antinicotinic compound MB327 against soman poisoning - Importance of experimental end point.
    Price ME; Whitmore CL; Tattersall JEH; Green AC; Rice H
    Toxicol Lett; 2018 Sep; 293():167-171. PubMed ID: 29127032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arrhythmias in organophosphate poisoning: effect of atropine and bispyridinium oximes.
    Worek F; Kleine A; Falke K; Szinicz L
    Arch Int Pharmacodyn Ther; 1995; 329(3):418-35. PubMed ID: 8546540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of atropine, HLö 7 and HI 6 on respiratory and circulatory function in guinea-pigs poisoned by O-ethyl S-[2-(diisopropylamino) ethyl] methylphosponothioate (VX).
    Worek F; Kirchner T; Szinicz L
    Pharmacol Toxicol; 1994 Nov; 75(5):302-9. PubMed ID: 7870702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicokinetics of the nerve agent (+/-)-VX in anesthetized and atropinized hairless guinea pigs and marmosets after intravenous and percutaneous administration.
    van der Schans MJ; Lander BJ; van der Wiel H; Langenberg JP; Benschop HP
    Toxicol Appl Pharmacol; 2003 Aug; 191(1):48-62. PubMed ID: 12915103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyridinium oximes: rationale for their selection as causal antidotes against organophosphate poisonings and current solutions for auto-injectors.
    Stojiljković MP; Jokanović M
    Arh Hig Rada Toksikol; 2006 Dec; 57(4):435-43. PubMed ID: 17265683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy studies of Reactive Skin Decontamination Lotion, M291 Skin Decontamination Kit, 0.5% bleach, 1% soapy water, and Skin Exposure Reduction Paste Against Chemical Warfare Agents, part 1: guinea pigs challenged with VX.
    Braue EH; Smith KH; Doxzon BF; Lumpkin HL; Clarkson ED
    Cutan Ocul Toxicol; 2011 Mar; 30(1):15-28. PubMed ID: 20942572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.